BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15983787)

  • 1. Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse.
    Fantegrossi WE; Kiessel CL; De la Garza R; Woods JH
    Psychopharmacology (Berl); 2005 Sep; 181(3):529-36. PubMed ID: 15983787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.
    Fantegrossi WE; Godlewski T; Karabenick RL; Stephens JM; Ullrich T; Rice KC; Woods JH
    Psychopharmacology (Berl); 2003 Mar; 166(3):202-11. PubMed ID: 12563544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of 5-HT in the impairment of thermoregulation observed in rats administered MDMA ('ecstasy') when housed at high ambient temperature.
    Saadat KS; O'shea E; Colado MI; Elliott JM; Green AR
    Psychopharmacology (Berl); 2005 Jun; 179(4):884-90. PubMed ID: 15650843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice.
    Fantegrossi WE; Kiessel CL; Leach PT; Van Martin C; Karabenick RL; Chen X; Ohizumi Y; Ullrich T; Rice KC; Woods JH
    Psychopharmacology (Berl); 2004 May; 173(3-4):270-7. PubMed ID: 14740148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL; Callaway CW; Geyer MA
    Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement.
    Fantegrossi WE; Ullrich T; Rice KC; Woods JH; Winger G
    Psychopharmacology (Berl); 2002 Jun; 161(4):356-64. PubMed ID: 12073162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW; Wing LL; Geyer MA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice.
    Curry DW; Young MB; Tran AN; Daoud GE; Howell LL
    Neuropharmacology; 2018 Jan; 128():196-206. PubMed ID: 28993129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
    O'Shea E; Escobedo I; Orio L; Sanchez V; Navarro M; Green AR; Colado MI
    Neuropsychopharmacology; 2005 Jul; 30(7):1312-23. PubMed ID: 15688085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
    Jones K; Brennan KA; Colussi-Mas J; Schenk S
    Addict Biol; 2010 Jul; 15(3):289-98. PubMed ID: 20477756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization to MDMA locomotor effects and changes in the functionality of 5-HT(2A) and D₂ receptors in mice.
    Varela MJ; Brea J; Loza MI; Maldonado R; Robledo P
    Behav Pharmacol; 2011 Aug; 22(4):362-9. PubMed ID: 21712712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the mechanisms mediating MDMA "Ecstasy"-induced increases in cerebro-cortical perfusion determined by btASL MRI.
    Rouine J; Kelly ME; Jennings-Murphy C; Duffy P; Gorman I; Gormley S; Kerskens CM; Harkin A
    Psychopharmacology (Berl); 2015 May; 232(9):1501-13. PubMed ID: 25366875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute concomitant effects of MDMA binge dosing on extracellular 5-HT, locomotion and body temperature and the long-term effect on novel object discrimination in rats.
    Rodsiri R; Spicer C; Green AR; Marsden CA; Fone KC
    Psychopharmacology (Berl); 2011 Feb; 213(2-3):365-76. PubMed ID: 20645080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
    Kehne JH; Ketteler HJ; McCloskey TC; Sullivan CK; Dudley MW; Schmidt CJ
    Neuropsychopharmacology; 1996 Aug; 15(2):116-24. PubMed ID: 8840347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.
    Ball KT; Rebec GV
    Psychopharmacology (Berl); 2005 Oct; 181(4):676-87. PubMed ID: 16001122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity, and neurotoxicity.
    Russell BR; Laverty R
    Pharmacol Biochem Behav; 2001 Mar; 68(3):565-74. PubMed ID: 11325413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the repeated administration of the compound 3,4-methylenedioxymethamphetamine on the response of rats to the 5-HT2A,C receptor agonist (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
    Granoff MI; Ashby CR
    Neuropsychobiology; 1998; 37(1):36-40. PubMed ID: 9438270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement.
    Fletcher PJ; Korth KM; Robinson SR; Baker GB
    Psychopharmacology (Berl); 2002 Jul; 162(3):282-91. PubMed ID: 12122486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain.
    Riegert C; Wedekind F; Hamida SB; Rutz S; Rothmaier AK; Jones BC; Cassel JC; Jackisch R
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):743-63. PubMed ID: 18248690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA-like behavioral effects of N-substituted piperazines in the mouse.
    Yarosh HL; Katz EB; Coop A; Fantegrossi WE
    Pharmacol Biochem Behav; 2007 Nov; 88(1):18-27. PubMed ID: 17651790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.